KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Restructuring Costs: 2022-2023

Historic Restructuring Costs for Nektar Therapeutics (NKTR) over the last 2 years, with Dec 2023 value amounting to $5.5 million.

  • Nektar Therapeutics' Restructuring Costs fell 31.54% to $1.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.5 million, marking a year-over-year decrease of 95.38%. This contributed to the annual value of $5.5 million for FY2023, which is 82.67% down from last year.
  • Nektar Therapeutics' Restructuring Costs amounted to $5.5 million in FY2023, which was down 82.67% from $31.7 million recorded in FY2022.
  • Nektar Therapeutics' Restructuring Costs' 5-year high stood at $31.7 million during FY2022, with a 5-year trough of $5.5 million in FY2023.
  • Over the past 2 years, Nektar Therapeutics' median Restructuring Costs value was $18.6 million (recorded in 2022), while the average stood at $18.6 million.
  • Data for Nektar Therapeutics' Restructuring Costs shows a maximum YoY tumbled of 82.67% (in 2023) over the last 5 years.
  • Nektar Therapeutics' Restructuring Costs (Yearly) stood at $31.7 million in 2022, then plummeted by 82.67% to $5.5 million in 2023.